Grove Bank & Trust’s Tenet Healthcare THC Stock Holding History

Grove Bank & Trust’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13	Closed	-$857	–	704
2023 Q3	$857	Buy	+13	New	+$972	﹤0.01%	706

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grove Bank & Trust's THC Position: Q4 2023 in Review

Grove Bank & Trust sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 13 shares — an estimated $857 sold.

Grove Bank & Trust first reported a position in THC in Q3 2023 and held it in 1 quarter. The position peaked at $857 in Q3 2023. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

Grove Bank & Trust reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
Grove Bank & Trust sold 13 Tenet Healthcare shares in Q4 2023, an estimated $857.
Grove Bank & Trust first reported a position in Tenet Healthcare in Q3 2023 and held it in 1 quarter.
Grove Bank & Trust's Tenet Healthcare position peaked at $857 in Q3 2023.
425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.